APA (7th ed.) Citation

Jensen, P. N., Fretts, A. M., Hoofnagle, A. N., McKnight, B., Howard, B. V., Umans, J. G., . . . Lemaitre, R. N. (2022). Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: The strong heart study. Cardiovascular Diabetology, 21(1), 1. https://doi.org/10.1186/s12933-022-01596-4

Chicago Style (17th ed.) Citation

Jensen, Paul N., et al. "Circulating Ceramides and Sphingomyelins and the Risk of Incident Cardiovascular Disease Among People with Diabetes: The Strong Heart Study." Cardiovascular Diabetology 21, no. 1 (2022): 1. https://doi.org/10.1186/s12933-022-01596-4.

MLA (9th ed.) Citation

Jensen, Paul N., et al. "Circulating Ceramides and Sphingomyelins and the Risk of Incident Cardiovascular Disease Among People with Diabetes: The Strong Heart Study." Cardiovascular Diabetology, vol. 21, no. 1, 2022, p. 1, https://doi.org/10.1186/s12933-022-01596-4.